Jun 2023 Articles

Articles
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
Nissen SE, Menon V, Nicholls SJ, et al.
Journal:
JAMA

First published: June 24, 2023 DOI: 10.1001/jama.2023.9696
View
- Share
Articles
Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT
Shah NP, McGuire DK, Cannon CP, et al.
Journal:
J Am Heart Assoc

First published: June 22, 2023 DOI: 10.1161/JAHA.122.029593
View
- Share
Articles
Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients
Toplak H, Bilitou A, Alber H, et al.
Journal:
Wien Klin Wochenschr

First published: June 8, 2023 DOI: 10.1007/s00508-023-02221-4
View
- Share
Articles
High cholesterol absorption: A risk factor of atherosclerotic cardiovascular diseases?
Simonen P, Öörni K, Sinisalo J, et al.
Journal:
Atherosclerosis

First published: June 2, 2023 DOI: 10.1016/j.atherosclerosis.2023.06.003
View
- Share
Articles
Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association
Kirkpatrick CF, Sikand G, Petersen KS, et al.
Journal:
J Clin Lipidol

First published: June 2, 2023 DOI: 10.1016/j.jacl.2023.05.099
View
- Share
Articles
Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers
Tokgozoglu L, Morrow DA, Nicholls SJ
Journal:
Eur Heart J

First published: June 1, 2023 DOI: 10.1093/eurheartj/ehad275
View
- Share

Jun 2023 Articles

Articles

Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients

Nissen SE, Menon V, Nicholls SJ, et al.

Articles

Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT

Shah NP, McGuire DK, Cannon CP, et al.

Articles

Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients

Toplak H, Bilitou A, Alber H, et al.

Articles

High cholesterol absorption: A risk factor of atherosclerotic cardiovascular diseases?

Simonen P, Öörni K, Sinisalo J, et al.

Articles

Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association

Kirkpatrick CF, Sikand G, Petersen KS, et al.

Articles

Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers

Tokgozoglu L, Morrow DA, Nicholls SJ

Articles

Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients

Nissen SE, Menon V, Nicholls SJ, et al.

Share

Articles

Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT

Shah NP, McGuire DK, Cannon CP, et al.

Share

Articles

Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients

Toplak H, Bilitou A, Alber H, et al.

Share

Articles

High cholesterol absorption: A risk factor of atherosclerotic cardiovascular diseases?

Simonen P, Öörni K, Sinisalo J, et al.

Share

Articles

Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association

Kirkpatrick CF, Sikand G, Petersen KS, et al.

Share

Articles

Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers

Tokgozoglu L, Morrow DA, Nicholls SJ

Share